WelTel LTBI: A Randomized Controlled Trial Protocol of a Text-Messaging Intervention to Improve Patient Adherence to Treatment for Latent Tuberculosis Infection | Zendy

Mia L. van der Kop | Zendy; Kirsten Smillie | Zendy; Jasmina Memetovic | Zendy; Kevin Elwood | Zendy; Jan Hájek | Zendy; Lehana Thabane | Zendy; Fawziah Marra | Zendy; Kadria Alasaly | Zendy; Darlene Taylor | Zendy; Richard Lester | Zendy

Open Access

WelTel LTBI: A Randomized Controlled Trial Protocol of a Text-Messaging Intervention to Improve Patient Adherence to Treatment for Latent Tuberculosis Infection

Author(s) -

Mia L. van der Kop,

Kirsten Smillie,

Jasmina Memetovic,

Kevin Elwood,

Jan Hájek,

Lehana Thabane,

Fawziah Marra,

Kadria Alasaly,

Darlene Taylor,

Richard Lester

Publication year - 2013

Publication title -

journal of mobile technology in medicine

Language(s) - English

Resource type - Journals

ISSN - 1839-7808

DOI - 10.7309/jmtm.2.4s.3

Subject(s) - medicine , psychological intervention , intervention (counseling) , randomized controlled trial , latent tuberculosis , tuberculosis , directly observed therapy , physical therapy , triage , family medicine , human immunodeficiency virus (hiv) , emergency medicine , nursing , mycobacterium tuberculosis , pathology

Successful treatment of latent tuberculosis infection (LTBI) is critical to reduce the impact of TB; however, in North America, fewer than half of individuals starting LTBI treatment complete therapy. While existing TB treatment adherence interventions have not yet proven consistently successful, evidence has shown that weekly text messages can improve treatment adherence in HIV. One of these evidence-based interventions is WelTel, a service involving weekly text-message ‘‘check-ins’’ with patients. The aim of this study is to determine the effectiveness of the WelTel intervention on adherence to LTBI treatment. The objectives of this study are to: 1) determine the effect of the WelTel intervention on completion of LTBI treatment; 2) determine the effect of the WelTel intervention on daily adherence to LTBI treatment; 3) measure patient satisfaction with the WelTel intervention; 4) evaluate the cost-effectiveness of the WelTel intervention. A multi-site randomized controlled trial will be conducted at three TB control clinics in British Columbia, Canada. Over two years, we expect to enroll 486 individuals diagnosed with LTBI and initiating isoniazid (INH) (300mg daily for nine months). Participants will be randomly allocated to an intervention or control arm (standard care) at a 1:1 ratio. Intervention arm participants will receive a weekly SMS ‘check-in’, ‘‘Are you OK?’’, to which they will be instructed to respond within 48 hours either ‘‘yes’’ or ‘‘no’’. A TB clinician will follow-up and triage any problems that are identified. Participants will be followed for one year, with a primary endpoint of treatment completion, defined as having taken at least 80% of prescribed doses within 12 months. Follow-up questionnaires will be used to assess participant satisfaction with the intervention. Costeffectiveness will be analyzed through decision-analytic modeling. Data will be analyzed according to intention to treat principles. Chi-squared tests will be used for categorical outcomes; and t-tests or MannWhitney U tests for continuous outcomes

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research